Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Fast Forward

Sacklers Launch PR Drive To Make Case For Opioid Manufacturing

Purdue Pharma, maker of OxyContin, has embarked on a new ad campaign after coming under fire for manufacturing and distributing the powerful opioid.

The company, owned by the Sackler family, is arguing in the ads placed in major newspapers, that is is part of the solution, not of the problem.

“We manufacture prescription opioids,” one of the ads states. “How could we not help fight the prescription and illicit opioid abuse crisis?”

The company, which has been accused of profiting from widespread abuse of OxyContin, noted in the ads that it has worked to support strict subscribing rules for opioids as well as limits on opioid painkillers.

Purdue is now being sued by several states and counties for providing misleading information about the dangers of the opioids it produces.

Contact Nathan Guttman at guttman@forward.com or on Twitter @nathanguttman

A message from our CEO & publisher Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

We’ve set a goal to raise $260,000 by December 31. That’s an ambitious goal, but one that will give us the resources we need to invest in the high quality news, opinion, analysis and cultural coverage that isn’t available anywhere else.

If you feel inspired to make an impact, now is the time to give something back. Join us as a member at your most generous level.

—  Rachel Fishman Feddersen, Publisher and CEO

With your support, we’ll be ready for whatever 2025 brings.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at editorial@forward.com, subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.

Exit mobile version